NCT03225170

Brief Summary

Background: Some women have a high chance of developing breast and ovarian cancer because of a change in a gene that is passed within a family from one generation to the next. These women with hereditary breast and ovarian cancer (HBOC) have to make hard choices about tests and treatments. Researchers want to study how to help women to feel ready to make those choices. A kind of writing exercise might help if it is done before genetic counseling. This writing exercise is called a self-affirmation (SA) exercise. It may lead to better communication during counseling and better behavioral outcomes. Objective: To see if an SA exercise done before HBOC genetic counseling could improve client communication and behavior. Eligibility:

  • Clients: Adult female \>=18 years of age with initial appointment for HBOC risk with genetic counselor at St. Luke's Health System
  • Genetic Counselors: Genetic counselors \>=18 years of age providing genetic counseling to clients at risk for HBOC Design: Clients will be screened by phone prior to their genetic counseling appointment. They will arrive 15 minutes early to their appointment. They will do a 10 to 15 minute survey and writing exercise. This includes questions about:
  • Things that are important to them
  • How they are feeling prior to the appointment After their genetic counseling appointment, they will take a 10- to 15-minute follow-up survey. It can be in the office or online. It will include questions about:
  • How they felt about the writing exercise
  • How they felt about their genetic counseling
  • If they had cancer
  • If they were offered and had genetic testing Genetic counselor participants will take a 2 to 5 minute survey after each session with a client in the study. This will include questions about how the client was in the session. They also will take a 10 to 15 minute survey at the end of the study. It will be about their opinions on the process of having their clients complete the writing exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 21, 2017

Completed
25 days until next milestone

Study Start

First participant enrolled

August 15, 2017

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 29, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2020

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

January 11, 2022

Completed
Last Updated

May 29, 2024

Status Verified

June 29, 2020

Enrollment Period

2.9 years

First QC Date

July 20, 2017

Results QC Date

October 20, 2021

Last Update Submit

May 28, 2024

Conditions

Keywords

Decision-MakingBRCA1BRCA2Genetic CounselingHBOC

Outcome Measures

Primary Outcomes (7)

  • Test Uptake: Number of Clients Who Indicated Intention to Have Genetic Testing

    Intention to have genetic testing was measured with a single survey item, "Do you plan to have genetic testing?" with response options of yes=1; maybe=2; no=3

    Assessed within 1 week after completing the genetic counseling session

  • Number of Clients Who Indicated "Intention to Talk With Family" About Genetic Testing Result

    Intention to talk with family was measured with a single categorical survey item, "Which best describes your plans to talk with your family members about genetic testing results (check the one answer that is most true for you)?"

    Assessed within 1 week after completing the genetic counseling session

  • Likelihood of Talking With Family Members

    Likelihood of talking with family members was measured with a single survey item on a 7 point scale, "How likely are you to share results with the relatives you selected?" with 1= Extremely unlikely; 7=Extremely likely

    Assessed within 1 week after completing the genetic counseling session

  • Decision Self-efficacy: Ability to Confidently Make Decision About Genetic Testing

    Decision Self-efficacy was measured with the 12 item Decision Self-efficacy Scale by O'Connor, 1995. Scores ranged from 1-5 with higher average scores indicating higher decision self-efficacy

    Assessed within 1 week after completing the genetic counseling session

  • Client Knowledge: Hereditary Breast and Ovarian Cancer (HBOC) Knowledge Post Counselling Session

    Hereditary Breast and Ovarian Cancer (HBOC) Knowledge was measured with an adapted 7-question scale based on the National Center for Human Genome Research Knowledge (NCHGRK) Scale \[Scherr et al. 2015; Kaphingst et al. 2012\]. All questions in the scale were presented as True/False. Each question in the scale had a correct answer (coded as 1) and incorrect answer (coded as 0). This adapted HBOC Knowledge Scale score was calculated by summing the total value across the seven questions, with a range of 0 (minimum score, all incorrect) to 7 (maximum score, all correct). Higher score indicates higher knowledge.

    Assessed within one week after completing the genetic counseling session

  • Patient Empowerment (Client Completed): Ability to Manage Information and Risk Associated With Hereditary Breast and Ovarian Cancer (HBOC) (Decisional Control, Cognitive Control, Behavioral Control, Emotional Regulation, and Hope)

    Patient empowerment (client completed) was measured with the 24 item Genetic Counseling Outcomes Scale (GCOS-24; McAllister et al, 2011) using 7-point score ranging from 1=strongly disagree to 7= strongly agree. Higher scores indicate higher empowerment.

    Assessed within one week after completing the genetic counseling session

  • Patient Empowerment (Genetic Counselor Completed): Client's Ability to Manage Information and Risk Associated With HBOC (Decisional Control, Cognitive Control, Behavioral Control, Emotional Regulation, and Hope)

    Patient empowerment (genetic counselor completed) was measured with the 24 item Genetic Counseling Outcomes Scale (GCOS-24; McAllister et al, 2011) using 7-point score ranging from 1=strongly disagree to 7= strongly agree. Higher scores indicate higher empowerment

    Assessed immediately after completing the genetic counseling visit

Secondary Outcomes (11)

  • Mammogram Intention After Counseling: Likelihood of Getting a Mammogram

    Assessed within one week after completing the genetic counseling session

  • Client Anxiety After Writing Exercise and Prior to Counseling

    Assessed immediately after completing the writing exercise and prior to the genetic counseling session

  • Perceived Effect of Writing Exercise on Genetic Counseling Visit: Number of Clients With Perceived Effect of Intervention After Writing Exercise

    Assessed within one week after completing the genetic counseling session

  • Perception That Writing Exercise Hindered Genetic Counseling Visit: Number of Clients

    Assessed within one week after completing the genetic counseling session

  • Perception That Intervention Improved Genetic Counseling Visit: Number of Clients

    Within 1 week after completing the genetic counseling session

  • +6 more secondary outcomes

Study Arms (2)

Self-affirmation (SA) group

EXPERIMENTAL

Immediately prior to the scheduled cancer genetic counseling appointment, clients: 1. completed standardized questionnaires on self-affirmation (SA) intervention that focused on positive values of personal importance. The SA intervention required clients to rank 11 items (artistic skills, athletics, business/money, creativity, independence, music, politics, relationships with friends and family, religious values, sense of humor, spontaneity) from most important to least important and to elaborate on one that was most important to them and why; 2. 6-item standardized measure of anxiety questionnaire; 3. after the genetic counseling session, clients were required to fill out a post session questionnaire

Behavioral: Self Affirmation (SA)

Control group

SHAM COMPARATOR

Immediately prior to the scheduled cancer genetic counseling appointment, clients: 1. completed similar standardized questionnaire as the SA group, with a non-affirming exercise. The non-intervention required clients to rank 11 items (artistic skills, athletics, business/money, creativity, independence, music, politics, relationships with friends and family, religious values, sense of humor, spontaneity) from most important to least important and to elaborate on the 9th ranked item and why it might be important to someone else; 2. 6-item standardized measure of anxiety questionnaire; 3. after the genetic counseling session, clients were required to fill out a post session questionnaire

Behavioral: Control

Interventions

Clients will be asked to rank artistic skills, athletics, business/money, creativity, independence, music, politics, relationships with friends and family, religious values, sense of humor, spontaneity from most important to least important. They will then be asked to write about the item that is most important to them and why it may be important to them.

Self-affirmation (SA) group
ControlBEHAVIORAL

Clients will be asked to rank artistic skills, athletics, business/money, creativity, independence, music, politics, relationships with friends and family, religious values, sense of humor, spontaneity from most important to least important. The control group will rank the list and be asked to write about the 9th ranked item and why it might be important to someone else.

Control group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Client Participants:
  • Must be female, at least 18 years old
  • Have an initial appointment for genetic counseling for HBOC risk at St. Luke's Health System
  • Must be able to read and write in English to participate
  • Pregnant women will be included
  • Genetic Counselor (GC) Participants:
  • Must be certified GCs who see clients with an indication for HBOC related genetic counseling at St. Luke's Health System

You may not qualify if:

  • Non-English speakers and illiterate subjects will be excluded
  • Clients who are unable to provide consent will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Luke's Health System

Kansas City, Missouri, 64111, United States

Location

Related Publications (4)

  • Scherr CL, Christie J, Vadaparampil ST. Breast Cancer Survivors' Knowledge of Hereditary Breast and Ovarian Cancer following Genetic Counseling: An Exploration of General and Survivor-Specific Knowledge Items. Public Health Genomics. 2016;19(1):1-10. doi: 10.1159/000439162. Epub 2015 Sep 22.

  • Kaphingst KA, Facio FM, Cheng MR, Brooks S, Eidem H, Linn A, Biesecker BB, Biesecker LG. Effects of informed consent for individual genome sequencing on relevant knowledge. Clin Genet. 2012 Nov;82(5):408-15. doi: 10.1111/j.1399-0004.2012.01909.x. Epub 2012 Aug 7.

  • Harris PR, Napper L. Self-affirmation and the biased processing of threatening health-risk information. Pers Soc Psychol Bull. 2005 Sep;31(9):1250-63. doi: 10.1177/0146167205274694.

  • Ferrer RA, Klein WM, Graff KA. Self-affirmation increases defensiveness toward health risk information among those experiencing negative emotions: Results from two national samples. Health Psychol. 2017 Apr;36(4):380-391. doi: 10.1037/hea0000460. Epub 2017 Feb 16.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Results Point of Contact

Title
Dr. Lori Erby
Organization
NHGRI

Study Officials

  • Lori Erby, Ph.D.

    National Human Genome Research Institute (NHGRI)

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2017

First Posted

July 21, 2017

Study Start

August 15, 2017

Primary Completion

June 29, 2020

Study Completion

June 29, 2020

Last Updated

May 29, 2024

Results First Posted

January 11, 2022

Record last verified: 2020-06-29

Locations